Cresco Labs Inc. (CRLBF) Comparison with companies in other sectors?

Cresco Labs Inc. has a share price of 337.80M. You can analyze Cresco Labs Inc. (CRLBF) competitors across different market sectors through stock heatmaps.

What are CRLBF's NET and operating margins?

Cresco Labs Inc. (CRLBF) operating margin is around 0.13, and net profit margin is approximately -0.12 as of the latest reports.

In what way does CRLBF's earnings per share (EPS) trend reflect its financial momentum?

Cresco Labs Inc. (CRLBF) EPS is -0.24 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Cresco Labs Inc. is -2.92, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Cresco Labs Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Cresco Labs Inc. like P/E which is -2.92, P/B which is 0.52, and PEG which is 0.32. Compare them with sector averages to evaluate if the stock is priced fairly.

Cresco Labs Inc.

CRLBF•PNK

Healthcare

Drug Manufacturers - Specialty & Generic

$0.68

$0.05(8.03%)

Fundamental Analysis of Cresco Labs Inc. (CRLBF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.24

P/E Ratio

-2.92

ROE

-0.18%

Net Margin

-0.12%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$236.39M

Shares OutstandingTotal number of shares issued

$337.80M

Book Value/ShareNet worth per share

$1.11

Revenue/ShareAnnual revenue per share

$2.02

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.24

Net MarginNet income as percentage of revenue

-11.86%

Operating MarginOperating income as percentage of revenue

12.99%

ROEReturn on shareholders' equity

-17.60%

ROAReturn on total assets

-6.17%

ROCEReturn on capital employed

7.27%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.31

Cash/ShareCash and equivalents per share

$0.39

FCF YieldFree cash flow as percentage of market cap

46.11%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for CRLBFFinancial Ratios Analysis details for CRLBF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for CRLBFSector Benchmarking details for CRLBF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Cresco Labs Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Cresco Labs Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Cresco Labs Inc.'s unique business strengths and challenges.

Key Financial Metrics for Cresco Labs Inc.

For Cresco Labs Inc., essential financial indicators include EPS -0.24, PE -2.92, and ROE -0.18. These key ratios reveal insights into Cresco Labs Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Cresco Labs Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Cresco Labs Inc.

Metrics like Net Margin -11.86% and ROA -6.17% shed light on how well Cresco Labs Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Cresco Labs Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Cresco Labs Inc.

Using ratios such as P/B Ratio 0.52 and PEG Ratio 0.32, investors can assess whether Cresco Labs Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Cresco Labs Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Cresco Labs Inc.

Financial health indicators, such as Debt/Equity Ratio 1.35 and Cash Flow $0.31, provide a snapshot of Cresco Labs Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Cresco Labs Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Cresco Labs Inc.

Investing in Cresco Labs Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Cresco Labs Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;